Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

Q: What does CUSIP 75943R102 represent in this 13F holders report?

CUSIP 75943R102 is the security identifier for RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q3 2024?

193 institutional investors reported RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 75943R102

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 4,389,099
Total 13F shares: 163,415,012
Share change: +35,484,908
Total reported value: $1,156,675,796
Put/Call ratio: 49%
Price per share: $7.08
Number of holders: 193
Value change: +$253,277,512
Number of buys: 114
Number of sells: 70

Quarterly Holders Quick Answers

What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024
Previous quarter: Q2 2024

Recent filing periods for CUSIP 75943R102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	636%	27,904,963	$181,940,359	—	30 Jun 2024	13F
VANGUARD GROUP INC	13F	Company	267%	11,704,866	$76,315,726	—	30 Jun 2024	13F
BlackRock Finance, Inc.	13F	Company	240%	10,542,667	$68,738,188	—	30 Jun 2024	13F
Casdin Capital, LLC	13F	Company	192%	8,448,574	$55,084,702	—	30 Jun 2024	13F
Bellevue Group AG	13F	Company	145%	6,377,115	$41,578,790	—	30 Jun 2024	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	115%	5,039,015	$32,855,000	—	30 Jun 2024	13F
STATE STREET CORP	13F	Company	97%	4,248,406	$27,699,607	—	30 Jun 2024	13F
JPMORGAN CHASE & CO	13F	Company	90%	3,963,401	$25,841,376	—	30 Jun 2024	13F
Nextech Invest Ltd.	13F	Company	88%	3,846,409	$25,078,587	—	30 Jun 2024	13F
NORGES BANK	13F	Company	76%	3,319,342	$21,642,110	—	30 Jun 2024	13F
BRAIDWELL LP	13F	Company	69%	3,006,799	$19,604,329	—	30 Jun 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	54%	2,364,797	$15,421,916	—	30 Jun 2024	13F
Boxer Capital, LLC	13F	Company	41%	1,819,132	$11,860,741	—	30 Jun 2024	13F
Finepoint Capital LP	13F	Company	37%	1,605,346	$10,466,856	—	30 Jun 2024	13F
Alphabet Inc.	13F	Company	36%	1,568,753	$10,228,270	—	30 Jun 2024	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	35%	1,520,340	$9,911,288	—	30 Jun 2024	13F
GOLDMAN SACHS GROUP INC	13F	Company	34%	1,484,518	$9,679,057	—	30 Jun 2024	13F
Logos Global Management LP	13F	Company	30%	1,300,000	$8,476,000	—	30 Jun 2024	13F
MPM BioImpact LLC	13F	Company	29%	1,274,459	$8,309,473	—	30 Jun 2024	13F
MORGAN STANLEY	13F	Company	28%	1,242,278	$8,099,656	—	30 Jun 2024	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	27%	1,191,183	$7,766,513	—	30 Jun 2024	13F
CITADEL ADVISORS LLC	13F	Company	27%	1,163,336	$7,584,951	—	30 Jun 2024	13F
BAKER BROS. ADVISORS LP	13F	Company	26%	1,160,117	$7,563,963	—	30 Jun 2024	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	26%	1,149,177	$7,492,634	—	30 Jun 2024	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	21%	909,037	$5,926,921	—	30 Jun 2024	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	19%	821,391	$5,355,469	—	30 Jun 2024	13F
NORTHERN TRUST CORP	13F	Company	19%	814,412	$5,309,966	—	30 Jun 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	18%	795,482	$5,186,543	—	30 Jun 2024	13F
Integral Health Asset Management, LLC	13F	Company	17%	750,000	$4,890,000	—	30 Jun 2024	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	17%	730,022	$4,759,743	—	30 Jun 2024	13F
S.c.a. Candriam	13F	Individual	16%	703,429	$4,586,143	—	30 Jun 2024	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	14%	616,220	$4,017,754	—	30 Jun 2024	13F
BESSEMER GROUP INC	13F	Company	13%	584,463	$3,811,000	—	30 Jun 2024	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	13%	562,855	$3,669,815	—	30 Jun 2024	13F
ArrowMark Colorado Holdings LLC	13F	Company	12%	541,124	$3,528,128	—	30 Jun 2024	13F
ALGERT GLOBAL LLC	13F	Company	11%	476,888	$3,109,000	—	30 Jun 2024	13F
PRUDENTIAL FINANCIAL INC	13F	Company	10%	450,345	$2,936,249	—	30 Jun 2024	13F
Nuveen Asset Management, LLC	13F	Company	10%	446,808	$2,913,189	—	30 Jun 2024	13F
TWO SIGMA ADVISERS, LP	13F	Company	9.7%	424,800	$2,769,696	—	30 Jun 2024	13F
Prosight Management, LP	13F	Company	8.8%	385,000	$2,510,200	—	30 Jun 2024	13F
Bank of New York Mellon Corp	13F	Company	8.1%	354,667	$2,312,427	—	30 Jun 2024	13F
FEDERATED HERMES, INC.	13F	Company	7.1%	312,444	$2,037,135	—	30 Jun 2024	13F
HighTower Advisors, LLC	13F	Company	6.9%	303,345	$1,981,000	—	30 Jun 2024	13F
HARBOURVEST PARTNERS LLC	13F	Company	6.8%	296,402	$1,932,541	—	30 Jun 2024	13F
BAILLIE GIFFORD & CO	13F	Company	6.5%	284,058	$1,852,058	—	30 Jun 2024	13F
MARSHALL WACE, LLP	13F	Company	6.3%	276,702	$1,804,096	—	30 Jun 2024	13F
Woodline Partners LP	13F	Company	6.2%	273,616	$1,783,976	—	30 Jun 2024	13F
Rhenman & Partners Asset Management AB	13F	Company	5.2%	230,000	$1,499,600	—	30 Jun 2024	13F
PDT Partners, LLC	13F	Company	5.2%	226,632	$1,477,641	—	30 Jun 2024	13F
AMERIPRISE FINANCIAL INC	13F	Company	5%	219,725	$1,432,607	—	30 Jun 2024	13F

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) as of Q3 2024

As of 30 Sep 2024, Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) was held by 193 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 163,415,012 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, VANGUARD GROUP INC, BlackRock, Inc., Casdin Capital, LLC, Bellevue Group AG, NORGES BANK, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and Nextech Invest Ltd.. This page lists 194 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

171

Q3 2024 holders

193

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 Value $	Q3 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.